Elevance Health: A High Conviction Defensive Blue Chip Buy

Elevance Health's (ELV) Q3 results gain on growing medical customer base and strong pharmacy product revenues. Adjusted net income is currently projected to be more than $33.00 per share for 2023.

Elevance Health (ELV) came out with quarterly earnings of $8.99 per share, beating the Zacks Consensus Estimate of $8.45 per share. This compares to earnings of $7.53 per share a year ago.

Elevance Health reported a better-than-expected third-quarter profit on Wednesday, helped by lower-than-expected medical costs for the health insurance provider.

Elevance Health (ELV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

The third-quarter results of Elevance (ELV) are likely to reflect strong rate adjustments and membership growth in the Health Benefits business.

Elevance Health (ELV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or HealthEquity (HQY). But which of these two companies is the best option for those ...

Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Elevance Health (ELV) is set to enhance its product suite and expand to 91 counties in 2024, improving the overall health of people.

Elevance Health (ELV) and BCBS Louisiana have opted to withdraw the acquisition application from the Louisiana Department of Insurance.

Elevance's (ELV) focus on expanding the capabilities of the Carelon platform is likely to position the company for long-term growth.

Omega Advisors leader Leon Cooperman (Trades, Portfolio) disclosed his portfolio for the second quarter earlier this month.

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.